Pregabalin Versus Acetaminophen for a Treatment of Chronic Neuropathic Painon Extremities after Cervical Surgery: A Prospective Randomized, Open-LabelPreliminary Study

T. Hirai, T. Yoshii, M. Enomoto, Tsuyoshi Yamada, Takashi Taniyama, H. Inose, Tsuyoshi Kato, and Atsushi Okawa
{"title":"Pregabalin Versus Acetaminophen for a Treatment of Chronic Neuropathic Painon Extremities after Cervical Surgery: A Prospective Randomized, Open-LabelPreliminary Study","authors":"T. Hirai, T. Yoshii, M. Enomoto, Tsuyoshi Yamada, Takashi Taniyama, H. Inose, Tsuyoshi Kato, and Atsushi Okawa","doi":"10.4172/2167-0846.1000273","DOIUrl":null,"url":null,"abstract":"Therapeutic efficacy of pregabalin (PGL) for reducing neuropathic pain in patients who received a cervical operation is unclear. The purpose of this prospective pilot study was to compare the efficacy and adverse events between PGL and acetaminophen (ACM) for residual neuropathic pain. Thirty-four patients who received cervical spine surgery at our hospital from September 2011 to April 2013 and were diagnosed with residual neuropathic pain in the extremities were enrolled and were randomized to receive PGL (50 mg/day initially as an induction dose for 2 weeks) or ACM (1200 mg/day) for 8 weeks. PGL dosage was adjusted to 50-150 mg/day according to the severity of pain using a visual analog scale (VAS) after a 2-week time point. The Neck Disability Index (NDI) and VAS were used to evaluate subjective pain of the extremities and sleep condition. Short Form-36 (SF-36) and Japanese Orthopedic Association Cervical Myelopathy Evaluation Questionnaire (JOACMEQ) were used to evaluate neurologic function. Thirty-three patients (PGL 19 cases, ACM 14 cases) completed 8 weeks of follow-up. The average VAS for pain and numbness significantly improved in both groups at the final visit. The scale for sleep improved in the PGL group but was unchanged in the ACM group. The proportion of patients with satisfactory improvement in sleep was 31.6% and 0% in the PGL and ACM groups, respectively. There was a significant difference in VAS for sleep only. There were no significant improvements in the NDI and each domain of JOACMEQ in both groups. The number of patients who complained of somnolence tended to be greater in the PGL group. Thus, both PGL and ACM administration improved residual neuropathic pain in patients treated with cervical spine surgery for myelopathy. PGL was more effective in reducing sleep interference related to refractory neuropathic pain compared with ACM.","PeriodicalId":16641,"journal":{"name":"Journal of Pain and Relief","volume":"356 1","pages":"1-5"},"PeriodicalIF":0.0000,"publicationDate":"2016-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pain and Relief","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2167-0846.1000273","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Therapeutic efficacy of pregabalin (PGL) for reducing neuropathic pain in patients who received a cervical operation is unclear. The purpose of this prospective pilot study was to compare the efficacy and adverse events between PGL and acetaminophen (ACM) for residual neuropathic pain. Thirty-four patients who received cervical spine surgery at our hospital from September 2011 to April 2013 and were diagnosed with residual neuropathic pain in the extremities were enrolled and were randomized to receive PGL (50 mg/day initially as an induction dose for 2 weeks) or ACM (1200 mg/day) for 8 weeks. PGL dosage was adjusted to 50-150 mg/day according to the severity of pain using a visual analog scale (VAS) after a 2-week time point. The Neck Disability Index (NDI) and VAS were used to evaluate subjective pain of the extremities and sleep condition. Short Form-36 (SF-36) and Japanese Orthopedic Association Cervical Myelopathy Evaluation Questionnaire (JOACMEQ) were used to evaluate neurologic function. Thirty-three patients (PGL 19 cases, ACM 14 cases) completed 8 weeks of follow-up. The average VAS for pain and numbness significantly improved in both groups at the final visit. The scale for sleep improved in the PGL group but was unchanged in the ACM group. The proportion of patients with satisfactory improvement in sleep was 31.6% and 0% in the PGL and ACM groups, respectively. There was a significant difference in VAS for sleep only. There were no significant improvements in the NDI and each domain of JOACMEQ in both groups. The number of patients who complained of somnolence tended to be greater in the PGL group. Thus, both PGL and ACM administration improved residual neuropathic pain in patients treated with cervical spine surgery for myelopathy. PGL was more effective in reducing sleep interference related to refractory neuropathic pain compared with ACM.
普瑞巴林与对乙酰氨基酚治疗颈椎术后四肢慢性神经性疼痛:一项前瞻性随机、开放标签的初步研究
普瑞巴林(PGL)减轻颈椎手术患者神经性疼痛的疗效尚不清楚。这项前瞻性初步研究的目的是比较PGL和对乙酰氨基酚(ACM)治疗残余神经性疼痛的疗效和不良事件。本研究纳入2011年9月至2013年4月在我院接受颈椎手术并诊断为肢体残留神经性疼痛的34例患者,随机分为PGL(最初50 mg/天作为诱导剂量,持续2周)和ACM (1200 mg/天)两组,持续8周。2周后根据疼痛程度采用视觉模拟评分法(VAS)调整PGL剂量至50 ~ 150mg /d。采用颈部失能指数(NDI)和VAS评估四肢主观疼痛和睡眠状况。使用SF-36和日本骨科协会颈脊髓病评估问卷(JOACMEQ)评估神经功能。33例患者(PGL 19例,ACM 14例)完成8周随访。在最后一次访问时,两组的疼痛和麻木的平均VAS显著改善。睡眠量表在PGL组有所改善,而在ACM组没有变化。PGL组和ACM组患者睡眠改善满意的比例分别为31.6%和0%。仅睡眠组的VAS评分有显著差异。两组患者的NDI和JOACMEQ各结构域均无明显改善。在PGL组中,抱怨嗜睡的患者数量往往更多。因此,PGL和ACM均可改善颈椎手术治疗脊髓病患者的残留神经性疼痛。与ACM相比,PGL在减少难治性神经性疼痛相关的睡眠干扰方面更有效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信